David Arkowitz - Net Worth and Insider Trading
David Arkowitz Net Worth
The estimated net worth of David Arkowitz is at least $2 Million dollars as of 2024-05-29. David Arkowitz is the CFO of Flexion Therapeutics Inc and owns about 220,719 shares of Flexion Therapeutics Inc (FLXN) stock worth over $2 Million. David Arkowitz is the CFO of Seres Therapeutics Inc and owns about 182,442 shares of Seres Therapeutics Inc (MCRB) stock worth over $167,628. David Arkowitz is also the EVP, CFO, CBO of AMAG Pharmaceuticals Inc and owns about 1,806 shares of AMAG Pharmaceuticals Inc (AMAG) stock worth over $24,833. Besides these, David Arkowitz also holds Spring Bank Pharmaceuticals Inc (SBPH) . Details can be seen in David Arkowitz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Arkowitz has not made any transactions after 2024-02-16 and currently still holds the listed stock(s).
Transaction Summary of David Arkowitz
David Arkowitz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Arkowitz owns 8 companies in total, including Flexion Therapeutics Inc (FLXN) , Proteostasis Therapeutics Inc (PTI) , and Spring Bank Pharmaceuticals Inc (SBPH) among others .
Click here to see the complete history of David Arkowitz’s form 4 insider trades.
Insider Ownership Summary of David Arkowitz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FLXN | Flexion Therapeutics Inc | 2021-05-10 | Chief Financial Officer |
| PTI | Proteostasis Therapeutics Inc | 2020-06-29 | director |
| SBPH | Spring Bank Pharmaceuticals Inc | 2020-06-24 | director |
 | | 2011-05-31 | EVP & CFO and CBO |
| | 2020-12-22 | director |
| | 2016-05-05 | director |
| | 2024-02-16 | Chief Financial Officer |
| | 2020-12-22 | director |
David Arkowitz Latest Holdings Summary
David Arkowitz currently owns a total of 4 stocks. Among these stocks, David Arkowitz owns 220,719 shares of Flexion Therapeutics Inc (FLXN) as of May 10, 2021, with a value of $2 Million and a weighting of 90.31%. David Arkowitz owns 182,442 shares of Seres Therapeutics Inc (MCRB) as of February 16, 2024, with a value of $167,628 and a weighting of 7.52%. David Arkowitz also owns 1,806 shares of AMAG Pharmaceuticals Inc (AMAG) as of May 31, 2011, with a value of $24,833 and a weighting of 1.11%. The other 1 stocks Spring Bank Pharmaceuticals Inc (SBPH) have a combined weighting of 1.05% among all his current holdings.
Latest Holdings of David Arkowitz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FLXN | Flexion Therapeutics Inc | 2021-05-10 | 220,719 | 9.12 | 2,012,957 |
| MCRB | Seres Therapeutics Inc | 2024-02-16 | 182,442 | 0.92 | 167,628 |
| AMAG | AMAG Pharmaceuticals Inc | 2011-05-31 | 1,806 | 13.75 | 24,833 |
| SBPH | Spring Bank Pharmaceuticals Inc | 2017-08-04 | 4,846 | 4.84 | 23,455 |
Holding Weightings of David Arkowitz
David Arkowitz Form 4 Trading Tracker
According to the SEC Form 4 filings, David Arkowitz has made a total of 4 transactions in Flexion Therapeutics Inc (FLXN) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Flexion Therapeutics Inc is the sale of 2,229 shares on May 10, 2021, which brought David Arkowitz around $16,116.
According to the SEC Form 4 filings, David Arkowitz has made a total of 2 transactions in Seres Therapeutics Inc (MCRB) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Seres Therapeutics Inc is the sale of 3,939 shares on February 16, 2024, which brought David Arkowitz around $4,254.
According to the SEC Form 4 filings, David Arkowitz has made a total of 0 transactions in AMAG Pharmaceuticals Inc (AMAG) over the past 5 years. The most-recent trade in AMAG Pharmaceuticals Inc is the acquisition of 1,500 shares on May 31, 2011, which cost David Arkowitz around $19,845.
More details on David Arkowitz's insider transactions can be found in the Insider Trading History of David Arkowitz table.Insider Trading History of David Arkowitz
- 1
David Arkowitz Trading Performance
GuruFocus tracks the stock performance after each of David Arkowitz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Arkowitz is -7.79%. GuruFocus also compares David Arkowitz's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Arkowitz within 3 months outperforms 3 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Arkowitz's insider trading performs compared to the benchmark.
Performance of David Arkowitz
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.14 | | | | | |
| Relative Return to S&P 500(%) | 1.25 | | | | | |
David Arkowitz Ownership Network
David Arkowitz Owned Company Details
What does Flexion Therapeutics Inc do?
Who are the key executives at Flexion Therapeutics Inc?
David Arkowitz is the Chief Financial Officer of Flexion Therapeutics Inc. Other key executives at Flexion Therapeutics Inc include Chief Regulatory Officer Kerry Wentworth , Chief Strategy Officer Christina Willwerth , and General Counsel Mark S. Levine .
Flexion Therapeutics Inc (FLXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Flexion Therapeutics Inc Insider Transactions
David Arkowitz Mailing Address
Above is the net worth, insider trading, and ownership report for David Arkowitz. You might contact David Arkowitz via mailing address: C/o Flexion Therapeutics, Inc., 10 Mall Road, Suite 301, Burlington Ma 01803.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
